Maxcyte (MXCT) Cash from Financing Activities (2020 - 2026)

Maxcyte (MXCT) has 7 years of Cash from Financing Activities data on file, last reported at $5000.0 in Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 98.69% year-over-year to $5000.0 in Q1 2026; TTM through Mar 2026 was $278000.0, a 83.99% decrease from a year earlier, with the FY2025 full-year figure at $656000.0, down 68.09% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $5000.0, down from $105000.0 in the prior quarter.
• Over the last five years, Cash from Financing Activities for MXCT reached as high as $1.5 million in Q1 2023 and fell as low as $5000.0 in Q1 2026.
• Historically, Cash from Financing Activities has averaged $455764.7 across 5 years, with a median of $383000.0 in 2025.
• On a YoY basis, Cash from Financing Activities climbed as much as 1087.96% in 2022 and fell as far as 99.76% in 2022.
• Year by year, Cash from Financing Activities stood at $1.2 million in 2022, then plunged by 59.77% to $493000.0 in 2023, then retreated by 16.43% to $412000.0 in 2024, then tumbled by 74.51% to $105000.0 in 2025, then slumped by 95.24% to $5000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $5000.0 in Q1 2026, $105000.0 in Q4 2025, and $14000.0 in Q3 2025.